PTH and chronic kidney disease: Also because the previously mentioned links of ADMA with a fundamental biomarker of mineral bone disorders like PTH [12] and the inverse seasonal fluctuations of ADMA and 25-OH Vit D[36], vitamin D receptor activation appears to be an interesting, novel pathway to explore to mitigate ADMA accumulation in CKD.